This topic contains a solution. Click here to go to the answer

Author Question: Order: 1 L TPN with 50 dextrose and 8 amino acids. Follow with 500 mL of 10 Intralipid solution. How ... (Read 64 times)

Pineappleeh

  • Hero Member
  • *****
  • Posts: 585
Order: 1 L TPN with 50 dextrose and 8 amino acids. Follow with 500 mL of 10 Intralipid solution. How many total kcal will the client receive? _____
 
  a. 3,320
  b. 1,070
  c. 3,270
  d. 2,770

Question 2

Concerning home medications, it is important for the health care provider to know which of the following? _______________
 
  a. Where and how medications are stored
  b. Which doctor prescribed the medications
  c. What pharmacy filled the prescription
  d. The name of the client's health insurance plans



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Pariscourtney

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

ANS: D

Answer to Question 2

ANS: A




Pineappleeh

  • Member
  • Posts: 585
Reply 2 on: Jul 3, 2018
YES! Correct, THANKS for helping me on my review


lcapri7

  • Member
  • Posts: 350
Reply 3 on: Yesterday
Gracias!

 

Did you know?

When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.

Did you know?

The longest a person has survived after a heart transplant is 24 years.

Did you know?

The U.S. Pharmacopeia Medication Errors Reporting Program states that approximately 50% of all medication errors involve insulin.

Did you know?

About one in five American adults and teenagers have had a genital herpes infection—and most of them don't know it. People with genital herpes have at least twice the risk of becoming infected with HIV if exposed to it than those people who do not have genital herpes.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library